Skip to content
Search

Latest Stories

Submit Guest Post

Sigma Pharmaceuticals wins national champion crown

INDIAN origin family-owned Sigma Pharmaceuticals won the ‘national champion’ crown at this year’s National Family Business Awards in the ‘health and care services’ category on Sunday (28).

The company said: “As we become a second-generation family business and continue to thrive and grow, this rewards the contribution of our extended family of over 500 valued colleagues, which is a fantastic achievement for us.”


Sigma Pharmaceuticals is owned and run by Indian origin family. It is located in Watford, Hertfordshire.

Employing over 350 staff, it is one of the largest independent short line pharmaceutical wholesalers in the UK. The company provides key services to the pharmaceutical industry, serving over 2,500 pharmacies, doctors, hospitals and care homes.

Sigma won the coveted award – given annually since 2008 to family-owned businesses in recognition of their extraordinary contribution to the British and Irish economies – just weeks after the company’s founder and CEO, Bharat Shah, was appointed CBE in the Queen’s Birthday Honours.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

Metro Bank

Metro Bank is exploring a sale three years after a £925m rescue deal brought Colombian billionaire Jaime Gilinski Bacal in as its majority shareholder

iStock

Three years after its £925m rescue, Metro Bank is looking for a buyer

  • Metro Bank has invited potential buyers to consider a takeover, although it says no active negotiations are under way
  • Majority shareholder Jaime Gilinski Bacal could make an estimated £427m paper gain on his investment
  • The lender has returned to profitability after cutting costs, reducing its workforce and shifting towards specialist lending

Metro Bank is looking for a buyer three years after a £925m rescue deal, opening the possibility of a lucrative exit for Colombian billionaire Jaime Gilinski Bacal, whose investment has risen sharply in value during the lender's turnaround.

The London-based bank announced on November 12 that it had begun a formal sale process as part of a wider strategic review. Its shares rose by around 7 per cent following the announcement, valuing the business at approximately £1.3bn during Thursday's trading.

Keep ReadingShow less